Form D · Biotechnology
NX Development Corp.
Lexington, KY · CIK 0001635942
Offering snapshot reported May 27, 2016 · SEC filing
- Reported sold
- $700K Offering amount: $2.9M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 16, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 27, 2016 | Initial | $700,000 | No comparison | 11 | SEC filing |
| Mar 12, 2015 | Initial | $1,807,974 | No comparison | 31 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-264008
Source: Form D, filed May 27, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Brohman | Executive |
| Alan Ezrin | Director, Executive |
| Fred Mermelstein | Director |
| Gregory Murdock | Director |
| Robert Saunders | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
462 East High Street Suite 125 A
Lexington, KY, 40507
Lexington, KY, 40507